Bio-Rad Hits 52-Week High; Stratagene Leads Index | GenomeWeb
Shares in Bio-Rad Laboratories hit a 52-week high this week, closing Monday at $80.42, up 2.4 percent for the trading period ended Monday — a day earlier than normal due to the Thanksgiving holiday in the US this week. Stratagene led all gainers in the BCW Index with a 7.5 percent jump for the week. Qiagen led decliners for the week with a drop of 4.9 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.